PharMerica CORP Accounts and Financing Receivable, after Allowance for Credit Loss
PharMerica CORP had Accounts and Financing Receivable, after Allowance for Credit Loss of $208.10 million as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsAndNotesReceivableNet · last filed 2016-08-09
- 2016-06-30: Accounts and Financing Receivable, after Allowance for Credit Loss $208.10M.
- 2016-03-31: Accounts and Financing Receivable, after Allowance for Credit Loss $199.50M.
- 2015-12-31: Accounts and Financing Receivable, after Allowance for Credit Loss $200.50M.
- 2015-09-30: Accounts and Financing Receivable, after Allowance for Credit Loss $195.80M.
| Period end | Accounts and Financing Receivable, after Allowance for Credit Loss | Accounts and Financing Receivable, after Allowance for Credit Loss as first filed |
|---|---|---|
| 2016-06-30 | $208.10M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $199.50M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $200.50M 10-Q · filed 2016-08-09 | |
| 2015-09-30 | $195.80M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $199.10M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $199.50M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $195.40M 10-Q · filed 2015-11-06 | $195.80M 10-Q · filed 2015-05-07 |
| 2014-09-30 | $213.70M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $188.10M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $186.20M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $199.40M 10-Q · filed 2014-11-06 | $199.90M 10-Q · filed 2014-05-01 |
| 2013-09-30 | $190.50M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $196.10M 10-Q · filed 2013-08-02 | |
| 2012-12-31 | $205.40M 10-Q · filed 2013-11-05 | $206.60M 10-Q · filed 2013-08-02 |